Business Description
CDT Equity Inc
NAICS : 541720
SIC : 2833
ISIN : US20678X3044
Total Employee Number:
4Description
CDT Equity Inc is a data-driven biopharmaceutical development company focused on identifying, enhancing, and advancing high-potential therapeutic assets through scientific innovation and strategic partnerships. It has evolved into a broader, more agile platform that leverages artificial intelligence, solid-form chemistry, and efficient asset repositioning to accelerate the development of novel treatments. The company's pipeline includes candidates that target autoimmune disorders, as well as idiopathic male infertility, oncology, dermatology, rare disease and animal health. It has one operating segment focused on the research and development of clinical assets.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.95 | |||||
Equity-to-Asset | -1.27 | |||||
Debt-to-Equity | -0.11 | |||||
Debt-to-EBITDA | -0.02 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EPS without NRI Growth Rate | 61.1 |
Momentum Rank
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.34 | |||||
Quick Ratio | 0.34 | |||||
Cash Ratio | 0.12 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | -867.3 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROA % | -581.87 | |||||
ROIC % | -828.81 | |||||
3-Year ROIIC % | -7461.02 | |||||
ROC (Joel Greenblatt) % | -4283.75 | |||||
Moat Score | 3 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-EBIT | -0.04 | |||||
EV-to-EBITDA | -0.04 | |||||
EV-to-FCF | -0.08 | |||||
Earnings Yield (Greenblatt) % | -2439.52 | |||||
FCF Yield % | -836.75 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
CDT Equity Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | |||
| EPS (TTM) (€) | -4810.223 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | - | ||
| 14-Day ATR (€) | - | ||
| 20-Day SMA (€) | 9261 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (€) | 9261 - 9261 | ||
| Shares Outstanding (Mil) | 4.86 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
CDT Equity Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
CDT Equity Inc Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-13 | In 127 days | ||
| Second quarter earnings results for 2026 | 2026-08-14 | In 36 days | ||
| General meeting for 2025 | 2026-08-05 10:00 | In 28 days | ||
| First quarter earnings results for 2026 | 2026-07-10 | In 1 day | ||
| Annual report for 2025 | 2026-04-15 | 9,261.00 (+0.00%) | ||
| 0.04:1 Stock Split | 2026-03-27 | 9,261.00 (+0.00%) | ||
| Third quarter earnings results for 2025 | 2025-11-13 | 9,261.00 (+0.00%) | ||
| 0.125:1 Stock Split | 2025-10-13 | 9,261.00 (+0.00%) | ||
| Second quarter earnings results for 2025 | 2025-08-14 | 9,261.00 (+0.00%) | ||
| General meeting for 2024 | 2025-08-05 10:00 | 9,261.00 (+0.00%) |
Show
Entries
CDT Equity Inc Frequently Asked Questions
What is CDT Equity Inc(FRA:ZK7)'s stock price today?
The current price of FRA:ZK7 is €9261.00. The 52 week high of FRA:ZK7 is €9261.00 and 52 week low is €9261.00.
When is next earnings date of CDT Equity Inc(FRA:ZK7)?
The next earnings date of CDT Equity Inc(FRA:ZK7) is 2026-07-10 Est..
Does CDT Equity Inc(FRA:ZK7) pay dividends? If so, how much?
CDT Equity Inc(FRA:ZK7) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on CDT Equity Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers